Ind-Swift Ltd
₹15.76▲ +0.91 (+6.13%)
INDSWFTLTD·NSE·Healthcare
Market Cap
—
PE Ratio
0.30
Volume
6,45,158
Day High - Low
17.82 - 15.15
52W High-Low
—
₹15.76▲ +0.91 (+6.13%)
Market Cap—
PE Ratio0.30
Volume6,45,158
Day High - Low17.82 - 15.15
52W High-Low—
Ind-Swift Ltd (INDSWFTLTD): company summary
Ind-Swift Ltd (INDSWFTLTD) is an Indian listed company operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
Ind-Swift Ltd (INDSWFTLTD) is an Indian listed company operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
- Recent price move
- Ind-Swift Ltd last traded at ₹15.76, sharply up 6.13% on the day.
- Financial performance
- Revenue has been growing steadily at 9.0% a year over three years.
- Valuation multiples
- The stock trades at 0.3 times earnings, a discount to the Healthcare median of 32.0.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Last traded ₹15.76 on 12 Aug 2025 (432 days ago). Not a live price.
DocStoX Score
5.1/10
Weak
Fair Value
Sign in to see
ROE
—
P/E
0.30x
Cheap
Debt / Equity
—
Industry
Healthcare
Pharmaceuticals & Biotechnology
Overall View
Weak
Price performance
Day₹15.15
₹17.82
DocStoX take
Supported by valuation (7.5), but weakest on quality (4.0). The latest financials on file are more than 18 months old, so treat the fundamental measures with caution. Scored on 4 of 5 measures.
DocStoX score
Low confidence5.1
/10
Weak
Quality
Modest
ROCE 12.0%
Valuation
Cheap
P/E 0.3×
Growth
Slow
Revenue +9.3% 5Y CAGR
Risk
Elevated
Earnings variability 213%
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
—
52W High / Low
—
Dividend Yield
—
Promoter Holding
55.58%
EPS (TTM)
₹52.30
Book Value
—
Key highlights
- Healthy net margin (55%)
- Undemanding at 0× earnings
- Loss-making in some of the last 5 years
2 Positives1 Watchout
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals & Biotechnology
Explore Ind-Swift Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Ind-Swift Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Ind-Swift Ltd with peers
Related tools & concepts
Value Ind-Swift Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing